Distribuzione geografica
Continente #
NA - Nord America 2.162
EU - Europa 503
AS - Asia 92
AF - Africa 68
SA - Sud America 7
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 1
Totale 2.836
Nazione #
US - Stati Uniti d'America 2.138
FI - Finlandia 155
IE - Irlanda 77
NG - Nigeria 68
IT - Italia 61
DE - Germania 60
FR - Francia 48
CN - Cina 47
SE - Svezia 36
CA - Canada 24
NL - Olanda 23
IN - India 19
BE - Belgio 13
GB - Regno Unito 9
IL - Israele 9
TR - Turchia 6
RU - Federazione Russa 4
BR - Brasile 3
CL - Cile 3
CZ - Repubblica Ceca 3
JP - Giappone 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
ES - Italia 2
IR - Iran 2
UA - Ucraina 2
AU - Australia 1
BD - Bangladesh 1
EE - Estonia 1
EU - Europa 1
KG - Kirghizistan 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
SG - Singapore 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 2.836
Città #
Wilmington 429
Chandler 388
Helsinki 155
San Mateo 145
Ann Arbor 128
Ashburn 108
Leawood 81
Dublin 77
Lawrence 77
Princeton 77
Boardman 75
Benin City 68
Paris 48
New York 47
Shanghai 44
Fairfield 38
Woodbridge 37
Milan 24
Amsterdam 23
Abbiategrasso 21
Toronto 21
Pune 16
Seattle 14
Brussels 13
Norwalk 10
Phoenix 10
London 8
Los Angeles 8
San Diego 7
Kocaeli 6
Houston 5
Monmouth Junction 4
Falkenstein 3
Falls Church 3
Giussano 3
Gunzenhausen 3
Tappahannock 3
Alzate Brianza 2
Catania 2
Charleston 2
Chengdu 2
Council Bluffs 2
Male Hostice 2
Moscow 2
Oklahoma City 2
Pamplona 2
Sacramento 2
San Francisco 2
São Paulo 2
Tokyo 2
Vienna 2
Winnipeg 2
Alexandria 1
Andover 1
Belovo 1
Berlin 1
Bishkek 1
Bitola 1
Bratislava 1
Brisbane 1
Cambridge 1
Chisinau 1
Clearwater 1
Coimbatore 1
Frankfurt am Main 1
Gazipur 1
Hangzhou 1
Henderson 1
Islamabad 1
Knoxville 1
Kuala Lumpur 1
Las Vegas 1
Lima 1
Montreal 1
Newark 1
Novokuznetsk 1
Prague 1
Saint Paul 1
Santa Clara 1
Tallinn 1
Tel Aviv 1
Tirupur 1
Zanjan 1
Totale 2.288
Nome #
Activation of the VEGFC/VEGFR3 Pathway Induces Tumor Immune Escape in Colorectal Cancer 66
Bacterial sensor triggering receptor expressed on myeloid cells-2 regulates the mucosal inflammatory response 64
Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease 60
Unique role of junctional adhesion molecule-A in maintaining mucosal homeostasis in inflammatory bowel disease 58
Colitis-associated cancer: the dark side of inflammatory bowel disease 57
Effect of Tumor Necrosis Factor-alpha Blockade on Mucosal Addressin Cell-adhesion Molecule-1 in Crohn's Disease 54
Narrow-band imaging endoscopy to assess mucosal angiogenesis in inflammatory bowel disease: a pilot study 53
The bacterial sensor Triggering Receptor Expressed on Myeloid cells 2 (TREM-2) is a crucial pathogenic mediator in inflammatory bowel disease (IBD) 52
Colifagina, a novel preparation of 8 lysed bacteria ameliorates experimental colitis 52
The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation 51
Efficacy of a potent and safe vitamin D receptor agonist for the treatment of inflammatory bowel disease 50
VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis 49
mTOR-Dependent Stimulation of IL20RA Orchestrates Immune Cell Trafficking through Lymphatic Endothelium in Patients with Crohn's Disease 48
New insights into inflammatory bowel disease pathophysiology: Paving the way for novel therapeutic targets 46
VEGF-C-dependent stimulation of lymphatic function ameliorates experimental inflammatory bowel disease 46
Effect of Immunosuppression on Immune Response to Pneumococcal Vaccine in Inflammatory Bowel Disease: A Prospective Study 46
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter Study 46
Targeting S1P in Inflammatory Bowel Disease: New Avenues for Modulating Intestinal Leukocyte Migration 45
JAK-STAT Pathway Targeting for the Treatment of Inflammatory Bowel Disease 44
Unexpected role of anticoagulant protein C in controlling epithelial barrier integrity and intestinal inflammation. 44
Mesenchymal Stem Cells to Treat Digestive System Disorders: Progress Made and Future Directions 43
The Microglial Innate Immune Receptor TREM2 Is Required for Synapse Elimination and Normal Brain Connectivity. 43
Colitis, microbiota and colon cancer: an infernal triangle 43
OP018 High-fat diet and inflammation drive intestinal fibrosis enhancing epithelial–mesenchymal transition through the activation of S1P3 signalling 42
Mesenchymal stromal cells in inflammatory bowel disease: conspirators within the 'colitogenic niche'? 41
Rho-A prenylation and signaling link epithelial homeostasis to intestinal inflammation 41
Multiple pathogenic roles of microvasculature in inflammatory bowel disease : a Jack of all trades 41
MFSD2A Promotes Endothelial Generation of Inflammation-resolving Lipid Mediators and Reduces Colitis in Mice 41
Cathelicidins: A Novel Therapy for the Treatment of Intestinal Fibrosis 41
Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease : a prospective study 41
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 40
Antiendomysial antibody detection in fecal supernatants: In vivo proof that small bowel mucosa is the site of antiendomysial antibody production 40
Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature 40
The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications 39
Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease 39
Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus 38
The role of MAPK in governing lymphocyte adhesion to and migration across the microvasculature in inflammatory bowel disease 37
Contrast-enhancement at magnetic resonance enterography does not differentiate between fibrosis and inflammation in Crohn's disease: a prospective cohort study 37
Anti-TNF Antibodies and Autophagy: A Hidden Nexus for a Successful Therapeutic Response? 37
Involvement of CD40-CD40 Ligand in Uncomplicated and Refractory Celiac Disease 36
Intestinal myofibroblast-specific Tpl2-Cox-2-PGE(2) pathway links innate sensing to epithelial homeostasis 36
Identification of serum and tissue micro-RNA expression profiles in different stages of inflammatory bowel disease 36
Detection of anti-endomysial and anti-tissue transglutaminase autoantibodies in media following culture of oral biopsies from patients with untreated coeliac disease 36
Lymphatic endothelium contributes to colorectal cancer growth via the soluble matrisome component GDF11 35
Infliximab Inhibits Mucosal Pathological Angiogenesis in Crohn's Disease 34
Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine 33
NKp46-expressing human gut-resident intraepithelial Vδ1 T cell subpopulation exhibits high anti-tumor activity against colorectal cancer 33
Infliximab therapy inhibits inflammation-induced angiogenesis in the mucosa of patients with Crohn's disease 31
The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6 31
Single-dose versus short-course prophylactic antibiotics for peroral endoscopic myotomy: a randomized controlled trial 30
The Role of JAM-A in Inflammatory Bowel Disease: Unrevealing the Ties That Bind 29
Stimulation of CYP450-mediated ω-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 28
The atypical chemokine receptor D6 controls intestinal inflammation and inflammation-associated colon cancer 28
Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: A multicentre study 27
Sealing the broken barrier in IBD: intestinal permeability, epithelial cells and junctions 25
Tumor-associated macrophages and risk of recurrence in stage III colorectal cancer 25
TNF-stimulated gene-6 (TSG-6) is a key regulator in switching stemness and biological properties of mesenchymal stem cells 24
Journey through Crohn's Disease Complication: From Fistula Formation to Future Therapies 24
Programming of Intestinal Epithelial Differentiation by IL-33 Derived from Pericryptal Fibroblasts in Response to Systemic Infection 23
Proceedings of the signature series event of the international society for cellular therapy: "Advancements in cellular therapies and regenerative medicine in digestive diseases," London, United Kingdom, May 3, 2017 23
Hyaluronan Accelerates Intestinal Mucosal Healing through Interaction with TSG-6 23
In vitro Anti-inflammatory and Protective Effects of ibidì® on Intestinal Epithelial Cells 22
Endothelial Tpl2 regulates vascular barrier function via JNK-mediated degradation of claudin-5 promoting neuroinflammation or tumor metastasis 22
Mesenchymal Stem Cells in IBD: unMaSCing Their Therapeutic Mechanisms 21
Reciprocal influence of B cells and tumor macro and microenvironments in the ApcMin/+ model of colorectal cancer 21
Stimulation of CYP450-mediated omega-3 docosahexaenoic acid metabolism via MFSD2A as a novel therapy for inflammatory bowel disease 21
Unveiling role of sphingosine-1-phosphate receptor 2 as a brake of epithelial stem cell proliferation and a tumor suppressor in colorectal cancer 21
A Small CEACAM5 Peptide Restores the Protective Function of CD8+ Regulatory T Cells in Crohn’s Disease 20
Antiendomysial Antibody Detection in Biopsy Culture Allows Avoidance of Gluten Challenge in Celiac Children 20
Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression 20
The protein C pathway in intestinal barrier function: challenging the hemostasis paradigm 20
Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor 19
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel 19
Dysfunctional Extracellular Matrix Remodeling Supports Perianal Fistulizing Crohn's Disease by a Mechanoregulated Activation of the Epithelial-to-Mesenchymal Transition 18
The Multiple Faces of Integrin-ECM Interactions in Inflammatory Bowel Disease 16
GPR120 prevents colorectal adenocarcinoma progression by sustaining the mucosal barrier integrity 16
The IL23-IL17 Immune Axis in the Treatment of Ulcerative Colitis: Successes, Defeats, and Ongoing Challenges 16
Anti-Tissue Transglutaminase Antibodies in Arthritic Patients: A Disease-specific Finding? 12
The Inflammatory Bowel Disease Transcriptome and Metatranscriptome Meta-Analysis (IBD TaMMA) framework 11
Patient-derived tumor models: a more suitable tool for pre-clinical studies in colorectal cancer 11
Forty-Eight Hours of Biopsy Culture Improve the Sensitivity of the in Vitro Gliadin Challenge in the Diagnosis of Celiac Disease 10
Sphingosine 1-phosphate modulation and immune cell trafficking in inflammatory bowel disease 10
Sphingosine 1-Phosphate Modulation in Inflammatory Bowel Diseases: Keeping Lymphocytes Out of the Intestine 10
Mesalamine in the treatment of mild to moderate active Crohn's ileitis: Results of a randomized, multicenter trial 9
Fibrotic Strictures in Crohn’s Disease: Mechanisms and Predictive Factors 8
Pomegranate Extract Affects Gut Biofilm Forming Bacteria and Promotes Intestinal Mucosal Healing Regulating the Crosstalk between Epithelial Cells and Intestinal Fibroblasts 6
ImmUniverse Consortium: Multi-omics integrative approach in personalized medicine for immune-mediated inflammatory diseases 5
Fibro-Stenosing Crohn’s Disease: What Is New and What Is Next? 1
Totale 2.918
Categoria #
all - tutte 21.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.202

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202031 0 0 0 0 0 0 0 0 0 0 0 31
2020/2021774 6 12 3 5 4 244 117 45 162 84 2 90
2021/2022455 27 3 8 77 4 2 12 54 41 38 157 32
2022/20231.103 182 65 96 118 107 85 3 76 184 104 67 16
2023/2024555 57 72 125 72 34 111 32 22 12 18 0 0
Totale 2.918